Since we found little evidence of canonical HH-GLI activation in our cell lines, driven by our previous findings in breast cancer cells21 where we found evidence of SHH and ERα interactions, we checked whether SHH-N could non-canonically bind the AR and contribute to its activity. Here, GLI1 is linked to breast cancer.